Cancer Medicine, Volume 14, Issue 23, December 2025.ABSTRACT Background Symptom management in myeloproliferative neoplasms (MPN) remains challenging despite advancements in disease‐directed therapies. This study assessed the impact of demographic, clinical, laboratory and treatment‐related variables on total symptom scores (TSS) and individual symptom scores in patients with polycythemia vera (PV ...
Muhammad Ali Khan +8 more
wiley +1 more source
Characteristics and clinical significance of cytogenetic abnormalities in polycythemia vera
Haematologica, 2017 Up to 20% of patients with polycythemia vera have karyotypic abnormalities at the time of the initial diagnosis. However, the cytogenetic abnormalities in polycythemia vera have not been well characterized and their prognostic impact is largely unknown ...
Guilin Tang +13 more
doaj +1 more source
Cerebellar venous thrombosis mimicking a cerebellar tumor due to polycythemia vera: a case report [PDF]
, 2021 Hongfeng Wen +4 more
openalex +1 more source
Second Primary Cancer After Bladder Cancer: A Comprehensive Analysis of a National Cancer Registry
Cancer Medicine, Volume 14, Issue 23, December 2025.ABSTRACT Background Bladder cancer (BC) is one of the most common cancers and many patients will experience long‐term survival. Non‐urothelial second primary cancers (SPC) relatively frequently occur in the population of BC survivors. Methods Czech National Cancer Registry was the principal data source for this study.
Tomas Buchler +5 more
wiley +1 more source
Polycythemia Vera: New Diagnostic Concept and Its Types
Клиническая онкогематология, 2016 Polycythemia vera (PV) is a clonal Ph-negative myeloproliferative disorder characterized by excessive myeloid proliferation of three hematopoietic cell lineages leading to ineffective myelopoiesis.
Alla Mikhailovna Kovrigina, V. V. Baikov
doaj +1 more source
Idiopathic noncirrhotic portal hypertension: current perspectives [PDF]
, 2016 The term idiopathic noncirrhotic portal hypertension (INCPH) has been recently proposed to replace terms, such as hepatoportal sclerosis, idiopathic portal hypertension, incomplete septal cirrhosis, and nodular regenerative hyperplasia, used to describe ...
D'AMATI, Giulia +5 more
core +1 more source
What's Your Diagnosis? A Case of Extreme Thrombocytosis in a Dog
Veterinary Clinical Pathology, EarlyView.
Stephanie F. Anderson +5 more
wiley +1 more source
Atypical chronic myeloid leukemia: From diagnosis to molecular features and therapeutic options
HemaSphere, Volume 9, Issue 12, December 2025.ABSTRACT Atypical chronic myeloid leukemia (aCML) is a rare form of myelodysplastic (MDS)/myeloproliferative neoplasm (MPN) overlap disorder characterized by neutrophilic leukocytosis with circulating immature myeloid cells (IMC), frequent hepatosplenomegaly, and poor prognosis with high rates of leukemic transformation.
Alessandra Iurlo +3 more
wiley +1 more source
Novel European Asiatic Clinical, Laboratory, Molecular and Pathobiological (2015-2020 CLMP) criteria for JAK2V617F trilinear polycythemia vera (PV), JAK2exon12 PV and JAK2V617F, CALR and MPL515 thrombocythemias: From Dameshek to Constantinescu-Vainchenker, Kralovics and Michiels [PDF]
, 2020 Michiels Jan Jacques +12 more
openalex +1 more source